| Sep 30 |
Adicet Bio to Present at the American Society of Gene & Cell Therapy’s (ASGCT) 2024 Advancing Gene + Cell Therapies for Cancer Conference
|
| Sep 30 |
Adicet Opens Enrollment for ADI-001 Phase 1 Clinical Trial in Autoimmune Diseases
|
| Sep 19 |
ADI-001 Clinical Biomarker Data Demonstrate Robust Tissue Trafficking and Complete B Cell Depletion in Secondary Lymphoid Tissue
|
| Sep 11 |
Adicet Bio narrows focus on lead asset
|
| Aug 27 |
Adicet Bio to Present at the H.C. Wainwright 26th Annual Global Investment Conference
|
| Aug 19 |
Adicet Bio Appoints Lloyd Klickstein, M.D., Ph.D. to the Board of Directors
|
| Aug 13 |
Adicet Bio GAAP EPS of -$0.33
|
| Aug 13 |
Adicet Reports Second Quarter 2024 Financial Results and Provides Business Updates
|
| Aug 1 |
Adicet Bio to Participate in Upcoming Investor Conferences
|
| Jul 25 |
Why Is Adicet Bio, Inc. (ACET) a Good One-Dollar Stock to Buy According to Hedge Funds?
|
